> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Slates Angiochem Meeting on Cancer Treatment
- URL: https://www.fdaweb.com/fda-slates-angiochem-meeting-on-cancer-treatment/
- Published: 2016-05-04T12:00:00.000Z
- Updated: 2026-09-14T20:59:32.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5135581

Angiochem says FDA has scheduled a 6/16 end-of-Phase 2 meeting to discuss clinical study results for the company’s ANG1005 for treating Leptomeningeal Carcinomatosis in patients with breast cancer and brain metastases. The company says the parties will determine the adequacy of current studies, and the safety of proceeding to Phase 3.